Covid-19: USAID supported SAMRIDH Healthcare to accelerate india’s response to the pandemic

By: |
July 17, 2021 2:07 PM

Regarding USAID’s support to SAMRIDH, USAID/India Acting Mission Director, Karen Klimowski, said: “USAID’s support to SAMRIDH reflects the United States’ strong commitment to accelerating India’s response to the COVID-19 pandemic.

SAMRIDH, USD, ndia Acting Mission Director, Karen Klimowski,, India's response to Covid, pressing healthcare challengesUSAID, through the SAMRIDH facility, has also recently funded healthcare enterprises

The United States Agency for International Development (USAID)-supported SAMRIDH Healthcare Blended Financing Facility has committed $27 million to support India’s national health priorities, including oxygen delivery systems, cold chain storage for vaccines, supply chain management for COVID-19 medicines, training for healthcare workers, and other hospital and community-based activities that can be rapidly expanded to address the COVID-19 pandemic.

Regarding USAID’s support to SAMRIDH, USAID/India Acting Mission Director, Karen Klimowski, said: “USAID’s support to SAMRIDH reflects the United States’ strong commitment to accelerating India’s response to the COVID-19 pandemic. Through SAMRIDH, USAID is identifying and fast-tracking the deployment of solutions to some of the most pressing healthcare challenges posed by the pandemic including the shortage of medical oxygen and lack of adequate vaccine storage facilities.”

Ashwajit Singh, Managing Director, IPE Global said, “At a time when India’s healthcare systems are in urgent need of reinforcement, USAID’s additional support to SAMRIDH will help it to scale-up and deploy lifesaving health solutions. Through our continuing engagement with USAID, we support resilient and inclusive health systems, ensuring everyone has access to timely, affordable, and quality healthcare services.”

USAID, through the SAMRIDH facility, has also recently funded healthcare enterprises that include:

  • A healthcare company that is adding beds with oxygen-delivering equipment to hospitals that serve poor and marginalized communities
  • A manufacturer of low-cost defibrillators that can be used to treat heat-related emergencies in resource constrained hospitals;
  • A private company addressing the continuing need for cost-effective oxygen concentrators, which turn ambient air into oxygen suitable for the treatment of severely ill COVID-19 patients.

SAMRIDH is also mobilizing additional resources from bilateral and multilateral donors, corporations, financial institutions, and philanthropy, and adopting innovative funding mechanisms to attract capital from the public and private sectors to support health care solutions across India.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1A booster shot or an additional Covid-19 vaccine: Which one is better for you? Find out
21 in 2 people wants govt to suspend flights from countries where 20 Omicron cases detected: Survey
3With Omicron, third wave projected to hit India by February but may be milder than second